The Director of the US National Institutes of Health (NIH) and the Acting Commissioner of the US Food and Drug Administration (FDA) have finally acknowledged that existing federal regulations hinder clinical cannabis research.
Now the two federal agencies are suggesting that scientists be able to legally access cannabis products from sources other than the University of Mississippi – the only federally licensed supply source of marijuana for research purposes.
In a letter to Sen. Brian Schatz (D-HI), first obtained by Politico, the officials acknowledge that the existing monopoly on federally authorized cannabis production limits “the diversity of [cannabis] products and formulations available to researchers, [thus] slowing the development of cannabis-based medications.”
Read more at theleafonline.com
